Location: Home
  • search
  • go
  • Relate News
  • 1/15/2018Type 1 Diabetes on the Rise in China, Most New Cases in Adults
  • 12/21/2017vTv Therapeutics Licenses GLP-1r Agonist Diabetes Program to Huadong P...
  • 12/21/2017Fast Rising Price of Chinese APIs Puts Pressure on Bottom Lines of Ind...
  • 11/8/2017CFDA Suspends Import of Rabeprazole API from India for Chinese GMP Iss...
  • 10/30/2017Sumitomo Dainippon and Poxel Enter Partnership for Novel Diabetes Drug...
  • 10/10/2017Indian and Chinese Drugmakers Dominate Asia Power Ranking
  • 9/27/2017CFDA Approves Boehringer/Lilly's Jardiance (Empagliflozin) for Type 2 ...
  • 9/27/2017Novo Nordisk Diabetes Drug Approved in China
  • 9/22/2017Novo Nordisk Eyes Growth GLP-1 Diabetes Drugs in Untapped China
  • 9/14/2017China Sets Up The Changing Diabetes Foundation with Help of Novo Nordi...
  • 7/31/2017India Hesitates About Fosun's Acquisition of Gland Pharma
  • 7/5/2017Biological E Licenses Two of Takeda's Vaccines for India and China
  • 6/28/2017WSJ: Novo Nordisk Wagers Sales Growth Will Offset Price Cuts In China
  • 6/28/2017New Survey: China Faces the Largest Diabetes Epidemic in the World
  • 6/20/2017China Establishes National Center for Children's Health
  • 5/18/2017CFDA Issues Technical Guidelines on Extrapolation of Adult Drug Usage ...
  • 5/16/2017A Dual-Functional GLP-1 Analogue May Improve Insulin Sensitivity and H...
  • 5/16/20173SBio Enters Strategic Alliance with Eli Lilly for Insulin Products
  • 5/15/2017China Introduces Second Batch of Encouraged Pediatric Drug Products
  • 5/5/2017Uni-Bio Science Launches Best-in-Class Oral Anti-Diabetic Drug Mitigli...
  • 4/27/2017India to Make Key APIs to Reduce Dependence on China
  • 4/13/2017Chinese Journal Publishes the Findings of Largest Phase IV Trial of Ty...
  • 4/5/2017China Grants Approval to Boehringer/Lilly Drug for Diabetes
  • 3/29/2017India Clears Fosun's Acquisition of Gland Pharma
  • 3/13/2017CFDA Approves China's First SGLT2 Inhibitor for Type 2 Diabetes
  • 3/6/2017CDE Solicits Comments for Preclinical Safety Studies of Pediatric Drug...
  • 2/16/2017India Pressures CFDA to Act and Restore Supply of Rare Disease API
  • 1/17/2017The Diabetes Epidemic in China: An Integrated Review of National Surve...
  • 12/15/2016Pfizer Enters R&D Partnership with PegBio for Select Diabetes Drug...
  • 11/14/2016India Puts Chinese APIs on Radar over Quality Concerns
  • Page:7/16 Total number of articles:474: [First][<<] [5] [6] [7] [8] [9] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group